Skip to main content
Premium Trial:

Request an Annual Quote

OGT Transfers NGS Services to Source BioScience, Will Focus on Genomic Products

NEW YORK (GenomeWeb) – Oxford Gene Technology today announced it will direct customers using its next-generation sequencing (NGS) services to genomic services firm Source BioScience.

OGT will receive a commission from Source BioScience on any referrals or transferred orders. 

The move comes as part of a decision to focus on genomic products rather than services, the firm said in a statement. "Our strategic focus on the large and growing genomic medicine markets of cancer, molecular cytogenetics, and reproductive health has delivered significant commercial growth," OGT CEO Mike Evans said in a statement. "OGT's genomics products portfolio has been growing at a compound annual growth rate of over 60 percent over the last four years and we have thus aligned our strategy and resources behind our genomics product business."

OGT pointed to its 2014 acquisition of fluorescent in situ hybridization probe maker Cytocell as evidence of the shift towards genomic products.

Evans said that the firm will try to help customers transition smoothly, adding that OGT will license its analysis software to Source BioScience as part of the transfer. Under terms of the license, Source BioScience will pay OGT a royalty if it uses the software on orders other than those transferred or referred to it by OGT.

In an email, a spokesperson for OGT told GenomeWeb that no physical assets, trademarks, or people will be transferred to Nottingham, UK-based Source BioScience and that OGT will continue to provide array services and perform targeted sequencing for potential customers of its SureSeq NGS panels.

Financial and other details were not disclosed. 

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.